As of December 2025 Immunovant has a market cap of โน358.80 Billion. This makes Immunovant the world's 3438th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 9th, 2025 the market cap of Immunovant was reported to be: